Aignostics
Healthcare AI
Computational pathology / precision medicine
Series B
Aignostics is an AI healthcare company focused on computational pathology and precision medicine. It develops AI-powered products and services that analyze complex multimodal biomedical and pathology data to support drug discovery, translational research, clinical trials, and companion diagnostics for biopharma and diagnostics partners.
Company Details
- Website
- aignostics.com
- Headquarters
- Berlin, Germany
- Founded
- 2018
- Funding
- $34M Series B in Oct 2024; total funding reported at about $54M to $55M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring